Clinical trials in Orlando, Florida
Shaping the future of healthcare through life‑changing clinical trials in Orlando.
For more than 25 years, Orlando Immunology Center has led clinical trials in Orlando that helped develop every antiretroviral used to treat HIV today. In addition, our work contributed to the cure for Hepatitis C.

Participation benefits
Being part of clinical trials in Orlando should never be a burden.
For eligible participants, clinical trial participation may include:
- Study medications provided at no cost
- Study-related labs provided at no cost
- Study-related visits provided at no cost
- Monitoring by study-related providers
- Transportation assistance, when needed, through Lyft, Uber, or bus passes
- Stipend provided at each study visit
Our legacy
A legacy of innovation that makes OIC a trusted leader in clinical trials in Orlando.
OIC investigators have participated in the development of every commercially available HIV antiretroviral. In fact, our team also played an important role in the cure for Hepatitis C and partnered with the NIH on COVID-19 vaccines and treatments. As a result, when you join a study at OIC, you become part of that history.
Research conducted with
- Gilead
- Merck
- ViiV · GSK
- Janssen
- AbbVie
- NIH · NIAID
- Roche
- TaiMed
Looking for clinical care instead?
Importantly, Orlando Immunology Center is dedicated exclusively to clinical research. Instead, for primary care, sexual health, and HIV medicine, visit OIC Inspired — our allied clinic, an independent practice founded by the same physicians.
Latest news
News from our clinical trials in Orlando

New once-monthly PrEP study now enrolling
OIC begins enrollment for a Phase 3 trial of a monthly oral tablet for HIV prevention.

Dr. Rolle Featured in TheBodyPro on Advancing Diverse Clinical Trials
Dr. Rolle discusses leading clinical trials at one of Central Florida’s most diverse HIV treatment centers.

OIC presents at CROI 2026
New data from our once-weekly oral treatment studies presented at the year’s leading HIV conference.
Clinical Research